Climate Change Data

Hansoh Pharmaceutical Group Company Limited

Climate Impact & Sustainability Data (2022, 2023, 2024-01-01 to 2024-06-30)

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Corporate governance
  • Corporate behaviour
  • Product quality and safety
  • Healthcare for all
  • Human resources development
  • Environmental protection
  • Community progress

Environmental Achievements

  • Maintained MSCI ESG A rating
  • Scored 63 points on the S&P Global Corporate Sustainability Assessment (CSA), exceeding 95% of its peer companies worldwide
  • Selected as the only pharmaceutical company in China’s mainland to be included in the 2023 Sustainable Development Yearbook
  • awarded the Bloomberg Business Week/Chinese Edition 2022 ESG Leading Enterprise Award, the Ministry of Industry and Information Technology 2022 China Pharmaceutical Enterprise Social Responsibility Outstanding Project, 2022 China Pharmaceutical Listed Company ESG Competitiveness Top 5, HRoot “2022 Greater China Employer Excellence ”, Jiangsu Province 2022 Green Development Leading Enterprise

Social Achievements

  • Focus on enhancing access to innovative drugs in areas of critical clinical need
  • HRoot “2022 Greater China Employer Excellence ” award

Governance Achievements

  • Maintained MSCI ESG A rating
  • Established a three-layer organizational framework for risk management and internal control

Climate Goals & Targets

Environmental Challenges

  • Rapidly changing epidemic control
  • Deepening healthcare reform
  • Omicron variant spread and stringent preventive and control measures affecting main business
Mitigation Strategies
  • Proactive management response to minimize negative impact of the epidemic

Supply Chain Management

Climate-Related Risks & Opportunities

Awards & Recognition

  • Bloomberg Business Week/Chinese Edition 2022 ESG Leading Enterprise Award
  • Ministry of Industry and Information Technology 2022 China Pharmaceutical Enterprise Social Responsibility Outstanding Project
  • 2022 China Pharmaceutical Listed Company ESG Competitiveness Top 5
  • HRoot “2022 Greater China Employer Excellence ”
  • Jiangsu Province 2022 Green Development Leading Enterprise

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • environmental
  • social
  • governance

Environmental Achievements

  • MSCI ESG rating upgraded to AA in 2023
  • Ranked in the top 1% of the industry in terms of ESG score by S&P Global CSA, listed in the Sustainability Yearbook (China Edition) 2023 and honored as the “Industry Mover”.

Social Achievements

  • Achieved remarkable results in talent cultivation and access to healthcare
  • Won the Gold Award in The Asset ESG Corporate Awards 2023 and HRoot 2023 “Outstanding Employer” award for Greater China.

Governance Achievements

  • Continued to improve ESG performance
  • Board insisted on fulfilling its supervisory responsibilities through the ESG Committee

Climate Goals & Targets

Long-term Goals:
  • achieve carbon neutrality by 2055
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • China Patent Gold Award
  • Gold Award in The Asset ESG Corporate Awards 2023
  • HRoot 2023 “Outstanding Employer” award for Greater China

Reporting Period: 2024-01-01 to 2024-06-30

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Social Achievements

  • Continued to be listed in the Sustainability Yearbook (China Edition) 2024 published by S&P Global, ranking among the top 1% in the industry in terms of ESG score.
  • MSCI ESG rating upgraded to AA in October 2023.

Governance Achievements

  • Strengthened corporate behaviour and business ethics control mechanisms.
  • Developed integrity and compliance training.

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: S&P Global Corporate Sustainability Assessment

Awards & Recognition

  • TOP 1% in the Sustainability Yearbook (China Edition) 2024 published by S&P Global